Close Menu
Eye On IVD
  • Contact
  • About

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

In Vitro Diagnostics Stocks, 2025 Flu Season, Diasorin Reports

May 7, 2025

Clinical Laboratory Market Nears $400 Billion: Report

April 22, 2025

“It Just Wreaks Havoc” – Webinar Debates Tariff Impact on IVD, LDT Rule Vacation, Other Topics

April 4, 2025
Facebook X (Twitter) Instagram
LinkedIn
Eye On IVDEye On IVD
Subscribe
  • Home
  • Research report shop
  • IVD NEWS
  • Contact Us
  • About Us
Eye On IVD
Home»Uncategorized»“That’s Where the Money Is” – AI in IVD Webinar Identifies Profit Potential
Uncategorized

“That’s Where the Money Is” – AI in IVD Webinar Identifies Profit Potential

Bruce CarlsonBy Bruce CarlsonFebruary 28, 2025Updated:February 28, 2025No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Most IVDs are commodity tests, and growth of value and scope is the way to counter that, said Greg Powell, of Howe Sound research (an IVD market research company) on a recent webinar. Greg is the lead author of a 540-page market research study (Available for order on EYE ON IVD: ARTIFICIAL INTELLIGENCE IN IVD MARKETS – Eye On IVD ). He discussed his findings on a recent webinar.

Value and scope drives price and that drives IVD profits, Powell said. And the reason AI is essential to seeing better-than-average growth rates in IVD instead of low ones is because it can get to that value/scope equation sooner.

“To give you example, with syndromic testing you’ve increaed the scope people are able to charge more because you get 27 results instead of a single test. Cancer profiling is another, billings in the thousands of dollars per test because of the value of the scope.”

Conventional tests can achieve some of this dynamic, but AI processing power makes this far more realistic.

He cites the example of Luventix (www.luventix.com), an AI-based gas chromatography test as an example of how AI might change traditional testing.

“They’ve got a pattern recogniton gas chromatography urinalysis test. So theyre talkign about doing a lung cancer diagnosis based on a simple urinalysis test to suggst a patient may have a cancerous condition.”

Per Luventix website: “Urine metabolomic data is rich, extensive and an untapped resource for diagnostics. It’s sometimes perceived as too “messy” in terms of all the signals and the disparate data sets contained within it (environmental, dietary, inorganic compounds etc.). This has limited its use for diagnostic purposes.”

“Standard tests, Powell said, “peform patern recognition based on studying individual biomarker and having those be analysted and studied and measured again.” whereas the AI test can use the gas chromagraphic pattern to deliver a value of scope. Luventix is an example but there are other tests adding to value of scope.

We will report more findings from our webinar in future editions of the EYE.

  • Artificial Intelligence for In Vitro Diagnostics MarketsSelect options This product has multiple variants. The options may be chosen on the product page

    Artificial Intelligence for In Vitro Diagnostics Markets

    IVD $6,995.00 – $13,995.00
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Bruce Carlson
  • Website

Related Posts

In Vitro Diagnostics Stocks, 2025 Flu Season, Diasorin Reports

May 7, 2025

Sepsis Report Details Unique IVD Market Strategy

April 2, 2025

Nova Acquired, TB Tests In Jeopardy Amid Cuts?

March 28, 2025
Leave A Reply Cancel Reply

THE LATEST

MARKET INTELLIGENCE Demo

DON'T MISS

AI and IVD Links We Are Tracking

January 17, 2025

ADLM Takes On FDA LDT Rule, With a Little Help From Friends. Also Automatic Blood Draws and DNA Passports? Notes – 7/31

August 2, 2024

BD To Spin Off In Vitro Diagnostics Unit, Siemens and Football, Werfen

February 7, 2025
Stay In Touch
  • Twitter
  • LinkedIn
Don't Miss

In Vitro Diagnostics Stocks, 2025 Flu Season, Diasorin Reports

Uncategorized May 7, 2025

How are IVD stocks doing in the general market fall? About that huge flu season.…

Clinical Laboratory Market Nears $400 Billion: Report

April 22, 2025

“It Just Wreaks Havoc” – Webinar Debates Tariff Impact on IVD, LDT Rule Vacation, Other Topics

April 4, 2025

Sepsis Report Details Unique IVD Market Strategy

April 2, 2025

Subscribe to EYE ON IVD

Get the latest news about the in vitro diagnostics market, from the experts.

Eye On IVD
LinkedIn
  • Home
  • Research Report Shop
  • About
  • Contact
  • Subscribe
Copyright © 2024 Eye On IVD LLC. All Rights Reserved

Type above and press Enter to search. Press Esc to cancel.